The HRP Education & Outreach Office is happy to provide a specific training at your request. Please let us know what type of training you are looking for by completing the below questions.
Sponsored Program Services (SPS) is developing a comprehensive compliance program. As the program develops, opportunities will be listed on the links available on the sidebar.
| Name | Title | |
|---|---|---|
| Jen Lamontagne | Assistant Director, Business Integrations and Solutions | jennifer.lamontagne@uconn.edu |
| Paula Engler | Research Reporting Analyst and Research IT Help Desk | paula.engler@uconn.edu |
| Cyndi Guest | Faculty Accruals Specialist | cyndi.guest@uconn.edu |
| Charlie Tuttle | Oracle PL/SQL Developer/DBA and Research IT Help Desk | charlie@uconn.edu |
| Kristin Winot | Functional Analyst/Effort Reporting Specialist | kristin.winot@uconn.edu |
This procedure is pursuant to the provisions outlined in the NIH OSP Memorandum “Implementation Update: Promoting Maximal Transparency Under the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules” (NIH Notice: NOT-OD-25-082).
In compliance with the NIH Guidelines, the IBC meeting minutes document the committee’s review of experiments that fall within the scope of Section III. Research activities not subject to the NIH Guidelines are not reflected in these records.
| IBC Meeting | Date Approved | Link to Record |
| June 12, 2025 | TENTATIVE
IBC Review Scheduled: August 7, 2025 |
Pending Approval |
IBC minutes will remain posted for a minimum of five years.
In accordance with state FOI and the requirements of the NIH Guidelines, only approved minutes will be posted publicly. Records in draft form are not subject to public records requests.
As a condition for NIH funding of recombinant or synthetic nucleic acid molecule research, institutions shall ensure that such research conducted at or sponsored by the institution, irrespective of the source of funding, shall comply with the NIH Guidelines.
Information concerning noncompliance with the NIH Guidelines may be brought forward by any person. It should be delivered to both NIH OSP and the relevant institution. The institution, generally through the Institutional Biosafety Committee, shall take appropriate action. The institution shall forward a complete report of the incident recommending any further action to the Office of Science Policy, National Institutes of Health, preferably by e-mail to: NIHGuidelines@od.nih.gov; additional contact information is also available within the Guidelines and on the OSP website (www.osp.od.nih.gov).
In cases where NIH proposes to suspend, limit, or terminate financial assistance because of noncompliance with the NIH Guidelines, applicable DHHS and Public Health Service procedures shall govern. All NIH-funded or non-NIH funded projects involving recombinant or synthetic nucleic acid molecules must comply with the NIH Guidelines.
Non-compliance may result in: (i) suspension, limitation, or termination of financial assistance for the noncompliant NIH-funded research project and of NIH funds for other recombinant or synthetic nucleic acid molecule research at the institution, or (ii) a requirement for prior NIH approval of any or all recombinant or synthetic nucleic acid molecule projects at the institution.
The Institutional Biosafety Committee (IBC) of the University of Connecticut (UConn) is committed to promoting the advancement of research and teaching activities, by ensuring that all experiments involving biological materials are conducted in full compliance with local, state, and federal regulations and guidelines. As required by the National Institutes of Health (NIH) Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guidelines), all institutions that conduct research with recombinant/synthetic nucleic acids (rsNA) and receive NIH funding, must maintain an active IBC. With the cooperative effort of Principal Investigators (PIs), the IBC conducts risk assessments for hazards associated with the use of biological materials, and promotes the safe use of such materials by enhancing lab personnel’s understanding of biosafety practices and procedures, as defined in the Biosafety in Microbiological and Biomedical Laboratories (BMBL) issued by the Centers for Disease Control and Prevention (CDC).
Pursuant to Section IV-B-2 of the NIH Guidelines, the IBC was originally established to review and approve “Experiments Covered by the NIH Guidelines”, as defined under Section III. Compliance with the NIH Guidelines is a requirement for institutions that accept NIH funding and conduct covered experiments. As such, compliance with the Guidelines is a term and condition of funding for all labs at UConn working with rsNA, regardless of funding source.
Due to increased regulations and rapid advancements in life sciences research, the scope of the IBC has evolved over time. IBC approval is required for all biological materials including but not limited to:
The IBC collaborates with Biosafety to ensure compliance with other federal and state regulations, such as Connecticut Department of Public Health (DPH), Centers for Disease Control and Prevention (CDC), Animal Plant Health Inspection Service (APHIS), etc.
If you are interested in joining an exciting committee that oversees biological research at UConn, email ibc@uconn.edu or the IBC Program Director at danielle.delage@uconn.edu.
The IBC must comprise no fewer than five members. At least two members shall not be affiliated with the institution (apart from membership on the IBC). Unaffiliated members represent the interest of the surrounding community with respect to health and protection of the environment.
UConn’s IBC consists of faculty, staff, and unaffiliated community members. All committee members contribute to the professional competency necessary to review the broad scope of research and teaching activities at the University.
Last Revised: 03/03/2025
The Institutional Biosafety Committee (IBC) of the University of Connecticut (UConn) is committed to promoting the advancement of research and teaching activities, by ensuring that all experiments involving biological materials are conducted in full compliance with local, state, and federal regulations and guidelines. As required by the National Institutes of Health (NIH) Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guidelines), all institutions that conduct research with recombinant/synthetic nucleic acids (rsNA) and receive NIH funding, must maintain an active IBC. With the cooperative effort of Principal Investigators (PIs), the IBC conducts risk assessments for hazards associated with the use of biological materials, and promotes the safe use of such materials by enhancing lab personnel’s understanding of biosafety practices and procedures, as defined in the Biosafety in Microbiological and Biomedical Laboratories (BMBL) issued by the Centers for Disease Control and Prevention (CDC).
Pursuant to Section IV-B-2 of the NIH Guidelines, the IBC was originally established to review and approve “Experiments Covered by the NIH Guidelines”, as defined under Section III. Compliance with the NIH Guidelines is a requirement for institutions that accept NIH funding and conduct covered experiments. As such, compliance with the Guidelines is a term and condition of funding for all labs at UConn working with rsNA, regardless of funding source.
Due to increased regulations and rapid advancements in life sciences research, the scope of the IBC has evolved over time. IBC approval is required for all biological materials including but not limited to:
The IBC collaborates with Biosafety to ensure compliance with other federal and state regulations, such as Connecticut Department of Public Health (DPH), Centers for Disease Control and Prevention (CDC), Animal Plant Health Inspection Service (APHIS), etc.
If you are interested in joining an exciting committee that oversees biological research at UConn, email ibc@uconn.edu or the IBC Program Director at danielle.delage@uconn.edu.
The IBC must comprise no fewer than five members. At least two members shall not be affiliated with the institution (apart from membership on the IBC). Unaffiliated members represent the interest of the surrounding community with respect to health and protection of the environment.
UConn’s IBC consists of faculty, staff, and unaffiliated community members. All committee members contribute to the professional competency necessary to review the broad scope of research and teaching activities at the University.
Last Revised: 03/03/2025
UConn uses HuskySMS, an electronic management system, to review and approve IBC registrations and amendments. EHS must add new labs to the HuskySMS database. Once EHS sets up the lab’s dashboard, PIs and personnel will have access to the “Bio”, “Inspections”, and “Training” modules.
Log into HuskySMS with your UConn NetID and password.
IBC Registrations: Researchers must complete the Biological Summary within the “Bio” module, to register research or teaching activities that involve biological materials.
IBC Amendments: Once a lab’s registration is active, amendments can be completed with HuskySMS as well. Simply review and revise applicable sections of the bio-summary, and ensure the PI certifies and submits changes within the system.
Please feel free to reach out to ibc@uconn.edu with any questions regarding the HuskySMS Bio module.
To report incidents involving biological materials, please download and complete the Incident Reporting Form linked below. Examples of incidents that should be reported include: needlesticks, percutaneous or mucous membrane exposures, spills outside of primary containment, etc.
Biological Incident Reporting Form
Lab Specific Biosafety Manual (LSBM)
Due to state and federal regulations, LSBMs are required for all BSL-2 laboratories. Regulators such as CT DPH and NIH, will inspect to ensure BSL-2 labs LSBMs are available and accessible. Lab members must review the LSBM on an annual basis. Training dates can be handwritten on the form, or lab member training records can printed from HuskySMS and added to the binder.
Biosafety will provide template LSBM binders as needed. If you would like to schedule a time for an LSBM binder to be delivered to your lab prior to the Biosafety Audit, please send an email request to ibc@uconn.edu.
PIs are responsible for including laboratory specific information within the LSBM, to ensure the manual is specific to the biohazards in the lab. This may include, but is not limited to: Standard Operating Procedures (SOPs), agent specific Pathogen Safety Data Sheets, Bloodborne Pathogens fact sheets, etc.
Below, links can be found to pathogen risk assessments for some of the more common biohazards fat UConn. Feel free to incorporate them into your LSBM if applicable, or use them as a guide to create your own.
Last Revised: 02/28/2025
These guidelines are intended to assist investigators who may be at risk for or have received a directive from a federal funding agency to stop, pause, terminate or otherwise prematurely end a human research study. Please contact the IRB Office if you have any questions or need assistance.
